AFT Pharmaceuticals Ltd. (NZ:AFT)
:AFT
Want to see NZ:AFT full AI Analyst Report?
| Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 205.49M | $ 195.41M | $ 155.82M | $ 129.83M | $ 112.86M |
| Gross Profit | $ 89.19M | $ 88.27M | $ 72.16M | $ 61.30M | $ 48.50M |
| Operating Income | $ 11.70M | $ 24.23M | $ 18.67M | $ 20.08M | $ 11.33M |
| EBITDA | $ 21.52M | $ 27.72M | $ 20.40M | $ 21.12M | $ 12.43M |
| Net Income | $ 11.96M | $ 15.61M | $ 10.65M | $ 19.85M | $ 7.78M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 11.11M | $ 12.04M | $ 4.75M | $ 7.94M | $ 3.21M |
| Total Assets | $ 169.81M | $ 165.26M | $ 148.06M | $ 121.76M | $ 105.13M |
| Total Debt | $ 30.00M | $ 32.19M | $ 38.05M | $ 40.51M | $ 42.22M |
| Net Debt | $ 18.89M | $ 20.15M | $ 33.30M | $ 32.57M | $ 39.01M |
| Total Liabilities | $ 72.74M | $ 77.46M | $ 74.80M | $ 65.02M | $ 68.54M |
| Stockholders' Equity | $ 97.64M | $ 87.80M | $ 73.27M | $ 56.74M | $ 36.59M |
| Cash Flow | |||||
| Free Cash Flow | $ 6.22M | $ 16.02M | $ -173.00K | $ 6.64M | $ -8.66M |
| Operating Cash Flow | $ 13.18M | $ 25.55M | $ 9.00M | $ 12.22M | $ -2.43M |
| Investing Cash Flow | $ -6.95M | $ -9.53M | $ -9.18M | $ -5.58M | $ -6.23M |
| Financing Cash Flow | $ -6.81M | $ -10.63M | $ -6.98M | $ -3.91M | $ 2.52M |